Hydrotherapy in advanced heart failure: The cardio-HKT pilot study

Monaldi Archives for Chest Disease - Cardiac Series

Volumn 66, Issue 4, 2006, Pages 247-254

  Municinó, Annamaria ^a   Nicolino, Annamaria ^a   Milanese, Manlio ^a   Gronda, Edoardo ^b   Andreuzzi, Bruno ^b   Oliva, Fabrizio ^c   Chiarella, Francesco ^a  

^a SANTA CORONA HOSPITAL   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Aerobic training; Cardiopulmonary exercise test; Dilated cardiomyopathy; Hydrotherapy; Quality of life; Skeletal muscle de conditioning

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HOT WATER;

ADULT; AEROBIC EXERCISE; ARTICLE; BEHAVIOR THERAPY; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; FUNCTIONAL TRAINING; HEART FAILURE; HEART REHABILITATION; HUMAN; HYDROTHERAPY; LIFESTYLE MODIFICATION; PATIENT EDUCATION; QUESTIONNAIRE; SAFETY; STATISTICAL ANALYSIS; THERAPY EFFECT; TREATMENT OUTCOME; WALKING;

EID: 33846987860     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: 10.4081/monaldi.2006.515     Document Type: Article

References (44)

1. Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in patients with severe left ventricular dysfunction: hemodynamic and metabolic effects. Circulation 1988; 78: 506-515.
2. Coats AJS, Adamopoulos S, Radaelli A, McCAnce A, Meyer TE, Bernardi L, et al. Controlled trial of physical training in chronic heart failure: exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 1992; 85: 2119-2131.
3. Belardinelli R, Georgiu D, Cianci G, Purcaro A. Randomized, controlled trial of long term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life and clinical outcome. Circulation 1999: 99 (9): 1173-82.
4. Piepoli MF, Davos C, Francis DP, Coats AJ ExTra-MATCH Collaborative. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTra-MATCH). BMJ 2004; 328 (7433): 189.
5. Wilson JR, Martin JL, Schwartz D, Ferraro N. Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle. Circulation 1984; 69 (6): 1079-87.
6. Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL, Wilson JR. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992; 85: 1364-1373.
7. Wilson JR, Mancini DM. Factors contributing to the exercise limitation of heart failure. J Am Coll Cardiol 1993; 22 (4 Suppl A): 93A-98A.
8. Wilson JR, Mancini DM, Dunkman WB. Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure. Circulation 1993; 87 (2): 470-5
9. Hambrecht R, Niebauer J, Fiehn E, Kalberer B, Offner B, Hauer K, et al. Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol 1995; 25: 1239-49.
10. Sullivan MJ, Hawthorne MH. Exercise intolerance in patients with chronic heart failure. Prog Cardiovasc Dis 1995; 38: 1-12.
11. Le Jemtel TH, Low M, Mancini D. Physical training should be targeted to the periphery in patients with chronic heart failure. Heart Fail 1997; 13 (2): 92-95.
12. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999; 99: 2192-2217.
13. Jiang W, Kuchibhatla M, Cuffe MS, Christopher EJ, Alexander JD, Clary GL, et al. Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation 2004; 110: 3452-3456.
14. Oldridge NB. Compliance and dropout in cardiac exercise rehabilitation. J Cardiac Rehabil 1984; 4: 166-77.
15. Ades PA. Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med 345; 12: 892-902.
16. Hall J, Skevington SM, Maddison PJ, Chapman K. A randomized and controlled trial of hydrotherapy in rheumatoid arthritis. Arthritis Care Res 1996; 9 (3): 206-15.
17. Hall JBD, O'Hare P. The physiology of immersion. Physiotherapy 1990; 76 (9): 517-521.
18. Sramek P, Simeckova M, Janski L, Savlikova J, Vybiral S. Human Physiological responses to immersion into water of different temperatures. Eur J Appl Physiol 2000; 81 (5): 436-442.
19. Gabrielsen A, Sorensen VB, Pump B, Galatius S, Videbaek R, Bie P, et al. Cardiovascular and neuroendocrine responses to water immersion in compensated heart failure. Am J Physiol Heart Circ Physiol 2000; 279; H1931-H1940.
20. Perini R, Milesi S, Biancardi L, Pendergast DR, Veicsteinas A. Heart rate variability in exercising humans: effect of water immersion. Eur J Appl Physiol 1998; 77 (4); 326-32.
21. Sheldahl LM, Tristani FE, Clifford PS, Kalbfleish JH, Smits G, Hughes CV. Effect of head out immersion on response to exercise training. J Appl Phisiol 1986; 60: 1878-81.
22. Kinney EL, Cortada X, Ventura R. Cardiac size and motion during water immersion: implications for volume homeostasis. Am Heart J 1987 Feb; 113 (2 Pt 1): 345-9.
23. Smith DE, Kaye AD, Mubarek SK, Kusnick BA, Anwar M, Friedman IM, Nossaman BD. Cardiac Effects of Water Immersion in Healthy Volunteers. Echocardiography 1998 Jan; 15 (1): 35-42.
24. Gabrielsen A, Johansen L, Norsk P. Central cardiovascular pressures during graded water immersion in humans. J Appl Physiol 1993; 75: 581-585.
25. Tei C, Horikiri Y, Park JC, Jeong JW, Chang KS, Toyama Y, et al. Acute hemodynamic improvement by thermal vasodilatation in congestive heart failure. Circ 1995 15; 91 (10): 2582-90.
26. Epstein M. Renal effects of head out immersion in humans: a 15-year update. Physiol Rev 1992; 72: 563-621.
27. Cider A, Schaufelberger M, Stibrant Sunnerhagen K. Hydrotherapy - a new approach to improve function in the older patient with chronic heart failure. Eur J H Fail 2003; 5: 527-535.
28. Cider A, Svealy BG, Tang MS, Schaufelberger M, Andersson B. Immersion in warm water induces improvement in cardiac function in patients with chronic heart failure. Eur J Heart Fail 2006; 8: 308-313.
29. Meyer K. Exercise training in heart failure: recommendations based on current research. Med Sci Sports Exerc 2001; 33: 525-531.
30. Meyer K, Bucking J. Exercise in heart failure: should aqua therapy and swimming be allowed? Med Sci Sports Exerc 2004; 36 (12): 2017-23.
31. Ornish D, Scherwitz LW, Billings JH, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998; 280: 2001-7.
32. Sokoll LJ, Baum H, Collinson PO, et al. Multicenter analytical performance evaluation of the Elecsys proBNP assay. Clin Chem Lab Med 2004; 42: 965-72.
33. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two dimensional echocardiography. J Am Soc Echocardiogr 1989; 2: 358-267.
34. Lipkin D, Crake T, Poole-Wilson PA. Six minute walking test for assessing exercise capacity in chronic heart failure patients. BMJ 1986; 292: 653-655.
35. Borg G. Ratings of perceived exertion and heart rates during short term cycle exercise and their use in a new cycling strength test. Int Sports Med 1982; 3 (3): 153-8.
36. American Thoracic Society/American College of Chest Physician. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003: 167: 211-277.
37. Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during randomized, double-blind, placebo controlled trial of pimobendan. Pimobendan Multicenter Research group. Am Heart J 1992; 124 (4): 1017-25.
38. Jondeau G, Katz SD, Toussaint J-F, et al. Regional specific of peak hyperemic response in pts with congestive heart failure: correlation with peak aerobic capacity. J Am Coll Cardiol 1993; 22: 1399-1402.
39. Peterson AMW, Pendersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005; 98 (4): 1154-1162.
40. Schrier R, Abraham W. Hormones and hemodynamics in heart failure. N Engl J Med 1999; 341: 577-85.
41. Levin ER, Gardner DG, Samson WK. Natriuretic Peptides. N Engl J Med 1998; 339: 321-8.
42. Williams SG, Ng LL, O'Brein RJ, Taylor S, et al. Comparison of plasma N-brain natriuretic peptide, peak oxygen consumption, and left ventricular ejection fraction for severity of chronic heart failure. Am J Cardiol 2004; 93: 1560-1.
43. Kruger S, Graf J, Kunz D, Stickel T, Hanrath P, Janssens U. Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol 2002; 40: 718-22.
44. de Groote P, Dagorn J, Soudan B, Lamblin N, McFadden E, Bauters C. B-type natriuretic peptide and peak oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. J Am Coll Cardiol 2004; 43: 1584-9.